ASTRA Therapeutics Seed Round Closing
ASTRA Therapeutics SA, a start-up company developing precision drugs against eukaryotic pathogens, announced the successful closing of its CHF 7.75m seed financing round.
The investment was co-led by MIG Capital and Digitalis...
Placement of USD 110 Million Financing of Oculis Holding AG
Oculis Holding AG (Nasdaq: OCS; XICE: OCS), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, announced the placements of...
RetinAI acquired by EssilorLuxottica
EssilorLuxottica, a global leader in vision care and eyewear, has acquired Ikerian AG, a health technology company operating under the RetinAI brand, specializing in AI and data management in eyecare.
Claraspital Basel is being acquired by University Hospital Basel
The University Hospital Basel (USB), one of Switzerland's leading university hospitals, is acquiring St. Claraspital AG, a leading, systemically important hospital in north-western Switzerland, from St. Clara AG and the Ingenbohl Monastery.
Nuclidium AG closes Series B financing round
NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, announced the successful closing of its Series B financing round, raising CHF 79m (EUR 84m).
Mosanna Therapeutics raises USD 80m in Series-A-Funding
Mosanna Therapeutics AG closed its USD 80m Series A funding round.
Thommen Group acquires Wiederkehr Group
Thommen Group acquires 100% of the shares in Wiederkehr Recycling AG (Waltenschwil AG), AVO Wiederkehr AG (Schwarzenbach SG), SMV Wiederkehr Recycling GmbH (Lauchringen, Germany) and the companies Wierec Trading AG (Hünenberg, Zug) and Wierec Services GmbH (Waltenschwil AG), which also belong to the Wiederkehr Group.
Aktiia Secures USD 42m Series-B-Funding to Expand into New Markets
Aktiia, a blood pressure intelligence platform, has completed an oversubscribed USD 42m Series-B funding-round, bringing the company's total funding to date to USD 100m.
MCH Group and Bits & Pretzels establish joint venture
MCH Group and Bits & Pretzels are joining forces under the joint venture health.tech events AG and launching health.tech | global summit, a new international leading conference for digital innovations in healthcare.
Twing Group AG sells shares to Baculus Holding AG
VISCHER advised the owners of Twing Group AG in the sale of all their shares to Baculus Holding AG, a portfolio company of Nachfolgepartner AG.